Naokuni Uike

Best Publications

• Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

  Takashi Ishida;Tatsuro Joh;Naokuni Uike;Kazuhito Yamamoto

  871
  Citations

• Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.

  Junichi Kiyasu;Junichi Kiyasu;Hiroaki Miyoshi;Akie Hirata;Fumiko Arakawa

  524
  Citations

• Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma

  Kazuhito Yamamoto;Atae Utsunomiya;Kensei Tobinai;Kunihiro Tsukasaki

  499
  Citations

• Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.

  Michinori Ogura;Takashi Ishida;Kiyohiko Hatake;Masafumi Taniwaki

  460
  Citations

• Treatment and survival among 1594 patients with ATL

  Hiroo Katsuya;Kenji Ishitsuka;Atae Utsunomiya;Shuichi Hanada

  349
  Citations

• Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

  Yasushi Yatabe;Ritsuro Suzuki;Kensei Tobinai;Yoshihiro Matsuno

  295
  Citations

• Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients.

  R Kihara;Y Nagata;H Kiyoi;T Kato

  294
  Citations

• Analysis of Genetic Polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese Patients with Therapy-related Leukemia/Myelodysplastic Syndrome and de novo Acute Myeloid Leukemia

  Tomoki Naoe;Kunihiko Takeyama;Toshiya Yokozawa;Hitoshi Kiyoi

  270
  Citations

• Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma

  Hiroo Katsuya;Takeharu Yamanaka;Kenji Ishitsuka;Atae Utsunomiya

  258
  Citations

• Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor

  Yasuo Mori;Hiromi Iwasaki;Kentaro Kohno;Goichi Yoshimoto

  255
  Citations

• Disease evolution and outcomes in familial AML with germline CEBPA mutations

  Kiran Tawana;Jun Wang;Aline Renneville;Aline Renneville;Csaba Bödör

  243
  Citations

• Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma

  Takuya Fukushima;Yasushi Miyazaki;S Honda;F Kawano

  243
  Citations

• Involvement of interferon‐γ and macrophage colony‐stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults

  Koichi Akashi;Shin Hayashi;Hisashi Gondo;Shin-ichi Mizuno

  242
  Citations

• Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.

  Takashi Ishida;Masakatsu Hishizawa;Koji Kato;Ryuji Tanosaki

  200
  Citations

• Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study

  Kazuo Muroi;Koichi Miyamura;Masaya Okada;Takuya Yamashita

  189
  Citations

• Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

  T. Igarashi;Y. Kobayashi;M. Ogura;T. Kinoshita

  177
  Citations

• Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies

  S Ogawa;A Hangaishi;S Miyawaki;S Hirosawa

  153
  Citations

• Clinical outcomes of a novel therapeutic vaccine with Tax peptide‐pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study

  Youko Suehiro;Atsuhiko Hasegawa;Tadafumi Iino;Amane Sasada

  146
  Citations

• Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.

  Ritsuko Seki;Koichi Ohshima;Tomoaki Fujisaki;Naokuni Uike

  141
  Citations

• Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.

  Masami Kuniyoshi;Makoto Nakamuta;Hironori Sakai;Munechika Enjoji

  135
  Citations